uniQure Stocks Up With First Phase III Results of Hemophilia B Gene Therapy
Gene therapies for the rare blood clotting disorder hemophilia B have taken a step closer…
27/11/2020 - 5 minutes
Gene & Cell therapy
CDMOs Are the Unsung Heroes of the Gene and Cell Therapy Revolution
Cell and gene therapy is booming amid the ongoing pandemic, and this is driving up…
23/11/2020 - 5 minutes
The Return of Gene Therapy
Gene therapy is a hot area in the biotech industry right now, with many treatments…
04/11/2020 - 8 minutes
Bayer’s AskBio Acquisition Strong Statement For Gene Therapy in Europe
This week, German big pharma Bayer announced a €3.5B takeover of Asklepios BioPharmaceutical, a well…
30/10/2020 - 6 minutes
Sponsored
by Merck
Ensuring Viral Vector Supply for Gene Therapies
While the success of gene therapies has boosted investments in the sector, it has also…
26/10/2020 - 2 minutes
From Big Pharma to Startup CEO: Lessons from Kymriah Developer Gaurav Shah
Novartis’ Kymriah, one of the first CAR T-cell therapies to be approved to treat blood…
28/09/2020 - 9 minutes
Sponsored
by Biovian
What Factors can Ease the Complexity of Viral Vector Production for Gene Therapies?
While the global gene therapy market grows steadily, companies continue to face bottlenecks in the…
28/09/2020 - 7 minutes
Why Are There Only 11 Cell and Gene Therapies in Europe?
There is a lot of talk about how cell and gene therapy are going to…
21/09/2020 - 5 minutes
T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors
The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a…
14/09/2020 - 3 minutes
Why a US Presence Can Help European Biotechs Get Ahead
While there is no doubt that Europe has a thriving biotech scene, it can really…
24/08/2020 - 5 minutes
Record Funding for Gene and Cell Therapy Accompanies Turbulent Times
European companies developing advanced therapies such as gene and cell therapies secured at least €2.2B…
14/08/2020 - 5 minutes
Covid-19 Forces Gene Therapy Companies to Shift Strategy
Amid the Covid-19 pandemic, gene therapy companies are suffering, with clinical trials delayed and investors…
29/07/2020 - 4 minutes
